Koyfin Home > Directory > Health Care > Nymox Pharm Corp > EBITDA Margin

Nymox Pharm Corp EBITDA Margin Chart (NYMX)

Nymox Pharm Corp annual/quarterly EBITDA Margin from 2010 to 2020. An EBITDA margin is a measurement of a company's earnings before interest, taxes, depreciation, and amortization as a percentage of its total revenue.
  • Nymox Pharm Corp EBITDA Margin for the quarter ending March 03, 2020 was $-51,420m a 49.41% decrease of -25,405m year over year
  • Nymox Pharm Corp EBITDA Margin for the last 12 months ending June 06, 2020 was $-14,370m a 14.69% decrease of -2,112m year over year
  • Nymox Pharm Corp Annual EBITDA Margin for 2019 was $-11,000m a 67.66% decrease of -7,442m from 2018
  • Nymox Pharm Corp Annual EBITDA Margin for 2018 was $-3,558m a -66.06% increase of 2,350m from 2017
  • Nymox Pharm Corp Annual EBITDA Margin for 2017 was $-5,908m a 23.32% decrease of -1,378m from 2016
Other Margins & Efficiency Metrics:
  • Nymox Pharm Corp Return on Capital % for the quarter ending September 09, 2018 was -187.81 a -1,416.11% increase of 2,659.58 year over year
  • Nymox Pharm Corp Return on Equity % for the quarter ending September 09, 2018 was -298.46 a -11.24% increase of 33.54 year over year
View Chart On Koyfin

Quarterly NYMX EBITDA Margin Data

03/2020$-51,420m
12/2019$-8,265m
09/2019$-6,418m
06/2019$-26,015m
03/2019$-8,587m
12/2018$-14,479m
09/2018$-7,024m
06/2018$-2,750m
03/2018$-1,749m
12/2017$-3,151m

Annual NYMX EBITDA Margin Data

2019$-11,000m
2018$-3,558m
2017$-5,908m
2016$-4,530m
2015$-639m
2014$-160m
2013$-145m
2012$-247m
2011$-309m
2010$-939m